Gum Arabic
Gum Arabic is a pharmaceutical drug with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
3
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effects of Gum Arabic on Metabolic Syndrome Parameters in Postmenopausal Women
The Effect of Gum Arabic (GA) on Residual Renal Function in Adult Dialysis Patients in Abu Dhabi
Dietary Fiber for Fecal Incontinence
Effects of Gum Arabic Supplementation in Hemodialysis Patients
Using Gum Arabic for Cancer Patients to Protect From Oral Mucositis Caused by Chemotherapy: ِِِAn Experimental Study
Clinical Trials (8)
Effects of Gum Arabic on Metabolic Syndrome Parameters in Postmenopausal Women
The Effect of Gum Arabic (GA) on Residual Renal Function in Adult Dialysis Patients in Abu Dhabi
Dietary Fiber for Fecal Incontinence
Effects of Gum Arabic Supplementation in Hemodialysis Patients
Using Gum Arabic for Cancer Patients to Protect From Oral Mucositis Caused by Chemotherapy: ِِِAn Experimental Study
Gum Arabic as Antioxidant and Anti-inflammatory in Hemodialysis Patients
Gum Arabic as Immunomodulator In Rheumatoid Arthritis Patients
Gum Arabic as Fetal Hemoglobin Agent in Sickle Cell Anemia
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8